Regional Blood Flow Terminated Phase Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0033542 (Regional Blood Flow)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00709657The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head PerfusionBasic Science